Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Top Cited Papers
Open Access
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (11) , 1919-1928
- https://doi.org/10.1038/mt.2009.179
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical ModelsMolecular Therapy, 2009
- Transcriptional Enhancers Induce Insertional Gene Deregulation Independently From the Vector Type and DesignMolecular Therapy, 2009
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyJournal of Clinical Investigation, 2009
- Insertional Gene Activation by Lentiviral and Gammaretroviral VectorsJournal of Virology, 2009
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsJournal of Clinical Investigation, 2008
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Journal of Clinical Investigation, 2008
- DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transferNucleic Acids Research, 2008
- Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral VectorsMolecular Therapy, 2007
- Retroviral vector insertion sites associated with dominant hematopoietic clones mark “stemness” pathwaysBlood, 2006
- Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicityBlood, 2006